Diabetes Care, Vol 17, Issue 11 1264-1268, Copyright © 1994 by American Diabetes Association
Comparison of World Health Organization and National Diabetes Data Group procedures to detect abnormalities of glucose tolerance during pregnancy
DJ Pettitt, PH Bennett, RL Hanson, KM Narayan and WC Knowler
Diabetes and Arthritis Epidemiology Section, National Institute of Diabetes and Digestive and Kidney Diseases, Phoenix, Arizona 85014.
OBJECTIVE--To compare the one-step procedure proposed by the World Health
Organization (WHO) with the two-step procedure proposed by the National
Diabetes Data Group (NDDG) for the identification of abnormalities of
glucose tolerance during pregnancy. RESEARCH DESIGN AND METHODS--One
hundred twenty-seven non-diabetic Pima Indian women had a 75-g 2-h glucose
tolerance test (WHO criteria). Those with an elevated 1-h glucose
concentration (> or = 7.8 mmol/l) were referred for a 100-g 3-h glucose
tolerance test (National Diabetes Data Group criteria). The effectiveness
of the two test procedures was determined by comparing the frequency of
macrosomia and cesarean section as outcomes of pregnancy. RESULTS--Of 42
women with 1-h plasma glucose concentrations > or = 7.8 mmol/l, 13 had
no 100-g test, 27 had a normal test, and 2 had an abnormal test. Both women
(100%) with abnormal two-step 100-g tests also had abnormal one-step 75-g
tests, but only 2 of the 11 women (18%) with an abnormal one-step test had
an abnormal two-step test. Sixteen of the 127 women delivered babies
weighing > or = 4,000 g. Six of these women (38%) were correctly
identified as abnormal using the one-step test and one (6%) using the
two-step test. Of seven women delivering by cesarean section, four (57%)
had abnormal one-step tests, but none had an abnormal two-step test.
CONCLUSIONS--The one-step WHO test for glucose tolerance during pregnancy
was abnormal in a greater percentage of women with adverse outcomes than
the more cumbersome two-step NDDG test. The one-step test has the added
advantage of being directly comparable to the standard glucose tolerance
test used in nonpregnant women.